Philadelphia-based University of Pennsylvania Health System recorded an operating income of $189.4 million (2.8% operating margin) in the first half of fiscal 2026, up from an operating income of $117 million (2% margin) during the same period last year, according to its Feb. 20 financial report.
The system reported total operating revenue of $6.8 billion for the six months ended Dec. 31, up from $5.8 billion during the same period last year. Net patient service revenue was $5.7 billion, up from $5 billion during the same period last year. Other operating revenue was $1.1 billion, up from $847.9 million.
Total operating expenses were $6.3 billion in the first two quarters of 2026, up from $5.4 billion during the same period last year. Salaries, wages and employee benefits totaled $3.3 billion, up from $3 billion last year. Supplies and service expenses totaled $2.7 billion, up from $2.3 billion. Malpractice expenses were $125 million, up from $69.1 million last year.
Penn Medicine’s results for fiscal 2026 include Doylestown (Pa.) Health. The system acquired the 245-bed teaching hospital on April 1, 2025.
The seven-hospital system reported a net income of $554.4 million in the first half of 2026, up from $298.9 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
